ArticleClinical and molecular hepatology2018

Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study.

Young Min Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.